Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma.
about
Recurrent Glioblastoma: Where we standExternal beam re-irradiation, combination chemoradiotherapy, and particle therapy for the treatment of recurrent glioblastomaProcarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis.Central nervous system cancersMiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3ASynergistic inhibition of survival, proliferation, and migration of U87 cells with a combination of LY341495 and Iressa.Design and application of oncolytic HSV vectors for glioblastoma therapy.Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients.Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoEInfluence of far upstream element binding protein 1 gene on chemotherapy sensitivity in human U251 glioblastoma cells.Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort.Re-irradiation of recurrent pediatric ependymoma: modalities and outcomes: a twenty-year survey.Long Non-coding RNA TUSC7, a Target of miR-23b, Plays Tumor-Suppressing Roles in Human Gliomas.Radiation-induced gliomas.Hypofractionated stereotactic radiation therapy for recurrent glioblastoma: single institutional experience.Strategy for surveying the proteome using affinity proteomics and mass spectrometry.Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local controlEvolution of care for patients with relapsed glioblastoma.Factors influencing quality of life in adult patients with primary brain tumors.A Review of the Role of Re-Irradiation in Recurrent High-Grade Glioma (HGG).The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Esculin and its oligomer fractions inhibit adhesion and migration of U87 glioblastoma cells and in vitro angiogenesis.Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.Effect of hyperoxygenation on tissue pO2 and its effect on radiotherapeutic efficacy of orthotopic F98 gliomasBenefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.Evaluating novel radiation techniques for the treatment of cerebral metastases.Glioblastoma patients in Slovenia from 1997 to 2008.Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme.Patient specification quality assurance for glioblastoma multiforme brain tumors treated with intensity modulated radiation therapy.Investigating the Effect of Reirradiation or Systemic Therapy in Patients With Glioblastoma After Tumor Progression: A Secondary Analysis of NRG Oncology/Radiation Therapy Oncology Group Trial 0525.Risk of ischemia in glioma surgery: comparison of first and repeat procedures.Advances in Radiotherapy for Glioblastoma.Hypofractionated Re-irradiation after Maximal Surgical Resection for Recurrent Glioblastoma: Therapeutic Adequacy and Its Prognosticators of Survival.Levels of Anxiety and Depression Before Palliative Reirradiation Are Comparable to Those Before First Palliative Radiotherapy.
P2860
Q26765042-DA6D895F-07CC-4BD1-BBC6-0196FA44881EQ28067135-8F7DBFF5-19AA-4460-986D-0069343DFC36Q33402044-BAEB935E-C0D6-4BAA-B1B0-B25D5439CD68Q34014740-8C69CE49-CD93-4BA4-95F9-440184FB33C7Q34701490-80DAF3BE-2C3C-4322-B0E9-1E30F361A884Q34749647-C135C637-4F85-446D-9C79-6FCFA046E837Q35559877-DD1C35B6-9C38-4B6D-A06C-DC8DD01937B4Q35920319-81BF6AA8-E866-438F-936D-10CF648643EEQ36157048-159E6772-65D0-49BD-BAD6-8BE7D684CACFQ36502836-9F3DD146-BC79-4447-90BF-B5BB6AD39557Q36582394-EAF7A5F8-7F0C-4DF8-A8B6-87CBDCD1758DQ37000961-8105D70F-9905-4252-9468-80BABC0C259AQ37037444-014C3B83-8EEF-4BC2-B8E9-47B5675C3416Q37314044-3273D8E7-4618-408E-913D-E80C0AEADC84Q37316500-6A5128BF-E03C-4EDE-A871-E9B0F927F472Q37366417-B9D3D162-1532-4D10-A1F7-735741811108Q37398795-CB26B986-078B-4D3E-9697-FE3245767CA1Q37481209-26E14420-6C85-4122-8850-FEC3C82605A0Q37952240-02DA79B1-DF65-4EFA-BED4-AD598AB73BFEQ38055319-DC202498-711D-4946-8EDC-8ABBA8416C2EQ38161380-ACAC7690-8D8A-41F4-895A-F3485A4D5006Q38204289-6B57075C-AD83-4DB0-A26A-86BA96A7E277Q38828524-7DA08D93-7C31-4D9B-A050-56EABBC13989Q39352683-1EC19347-F27C-403E-A4E1-80C5630C34B0Q39660159-3A0D04C0-CAD5-4AEB-8DBD-E87C0717B6D9Q40259728-99736D52-4C0E-4FFC-A0BB-A9C0D5D2CE49Q41854870-1D0FB238-A91B-44A5-8705-83F9CCC42BF2Q41903842-7C9F0D17-F9D0-4E13-8A03-8477DE4C32B4Q42060733-733AF5EF-939C-4CD8-A0E4-3D3C6EE7F0DCQ42134285-72938779-A475-4939-A609-9647EE0490C0Q47987124-8D7E60BE-A23D-4CFD-B787-5C07D44921E5Q48710842-3A63803A-DC3E-4A62-8DF5-490443415F73Q49592876-5FD0EBBA-75C8-4DA1-8D4B-DDE03F06B7F2Q50049531-3DA0E4E1-086B-4E53-BD57-9A3A11D75AD8Q55382860-D0D18EF0-6D05-4018-88C9-1250821493CD
P2860
Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improvement, clinical course, ...... py for recurrent glioblastoma.
@en
Improvement, clinical course, ...... py for recurrent glioblastoma.
@nl
type
label
Improvement, clinical course, ...... py for recurrent glioblastoma.
@en
Improvement, clinical course, ...... py for recurrent glioblastoma.
@nl
prefLabel
Improvement, clinical course, ...... py for recurrent glioblastoma.
@en
Improvement, clinical course, ...... py for recurrent glioblastoma.
@nl
P2093
P1476
Improvement, clinical course, ...... py for recurrent glioblastoma.
@en
P2093
Anca L Grosu
Carsten Nieder
Michael Molls
Sabrina T Astner
P304
P356
10.1097/COC.0B013E31815E3FDC
P50
P577
2008-06-01T00:00:00Z